Detalhe da pesquisa
1.
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
Clin Exp Rheumatol;
42(5): 1043-1050, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38634362
2.
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.
Clin Exp Rheumatol;
38(1): 19-26, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31074721
3.
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
Mod Rheumatol;
28(3): 542-549, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28880727
4.
Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients.
Ann Rheum Dis;
80(5): e75, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32561608
5.
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study.
Clin Exp Rheumatol;
33(5): 688-93, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26311348
6.
Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
Rheumatology (Oxford);
53(9): 1664-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24729445
7.
Ten-year drug survival of anti-TNF agents in the treatment of inflammatory arthritides.
Drug Dev Res;
75 Suppl 1: S38-41, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25381973
8.
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events.
Front Immunol;
14: 1225160, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37720218
9.
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Front Med (Lausanne);
9: 923790, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35602493
10.
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study.
Front Med (Lausanne);
9: 850858, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35360719
11.
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations.
Front Immunol;
13: 873195, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35757699
12.
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic.
Expert Rev Clin Immunol;
17(6): 561-571, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33787418
13.
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights.
Expert Rev Clin Pharmacol;
14(6): 661-670, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33847204
14.
Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors.
Medicine (Baltimore);
100(11): e24833, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33725953
15.
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.
Clin Rheumatol;
40(10): 4039-4047, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33881676
16.
Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry.
Ann Rheum Dis;
74(1): e5, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25304319
17.
Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
Rheumatology (Oxford);
54(7): 1337, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26047991
18.
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis.
Arthritis Res Ther;
22(1): 290, 2020 12 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33380344
19.
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
Autoimmun Rev;
19(5): 102509, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32173513
20.
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors.
Biomed Res Int;
2019: 6107217, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30733963